批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2015/01/21 |
ORIG-1(原始申请) |
Approval |
Type 1 - New Molecular Entity |
STANDARD
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2025/08/06 |
SUPPL-88(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2025/03/12 |
SUPPL-84(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2024/10/04 |
SUPPL-80(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2024/08/16 |
SUPPL-82(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/11/21 |
SUPPL-66(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/10/31 |
SUPPL-63(补充) |
Approval |
Efficacy-New Indication |
STANDARD
|
|
|
| 2023/10/06 |
SUPPL-73(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/07/24 |
SUPPL-67(补充) |
Approval |
Manufacturing (CMC)-Control |
N/A
|
|
|
| 2023/07/24 |
SUPPL-55(补充) |
Approval |
Labeling-Medication Guide,Labeling-Package Insert |
STANDARD
|
|
|
| 2023/07/24 |
SUPPL-54(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/05/11 |
SUPPL-44(补充) |
Approval |
Efficacy-Manufacturing Change With Clinical Data |
STANDARD
|
|
|
| 2021/12/22 |
SUPPL-51(补充) |
Approval |
Efficacy-New Indication |
PRIORITY
|
|
|
| 2021/12/22 |
SUPPL-50(补充) |
Approval |
Efficacy-New Indication |
PRIORITY
|
|
|
| 2021/05/28 |
SUPPL-43(补充) |
Approval |
Efficacy-New Indication |
STANDARD
|
|
|
| 2020/06/16 |
SUPPL-35(补充) |
Approval |
Efficacy-New Indication |
PRIORITY
|
|
|
| 2020/01/29 |
SUPPL-31(补充) |
Approval |
Efficacy-New Dosing Regimen |
STANDARD
|
|
|
| 2018/06/19 |
SUPPL-5(补充) |
Approval |
Efficacy-New Indication |
STANDARD
|
|
|
| 2018/01/23 |
SUPPL-13(补充) |
Approval |
Efficacy-Labeling Change With Clinical Data |
STANDARD
|
|
|
| 2017/09/15 |
SUPPL-16(补充) |
Approval |
Labeling-Package Insert,Labeling-Medication Guide |
STANDARD
|
|
|
| 2016/01/15 |
SUPPL-2(补充) |
Approval |
Efficacy-New Indication |
|
|
|
| 2016/01/15 |
SUPPL-1(补充) |
Approval |
Efficacy-New Indication |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:SECUKINUMAB; 剂型/给药途径:INJECTABLE;INJECTION; 规格:150MG/ML; 治疗等效代码:TBD<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 125504 |
001 |
BLA |
COSENTYX |
SECUKINUMAB |
INJECTABLE;INJECTION |
150MG/ML |
Prescription |
TBD |
No |
TBD |
--
|
NOVARTIS PHARMS CORP |